LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX)

Q: What does CUSIP 528872302 represent in this 13F holders report?

CUSIP 528872302 is the security identifier for LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in Q4 2023?

103 institutional investors reported LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 528872302

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 444,558,533
Total 13F shares: 182,858,180
Share change: -6,227,440
Total reported value: $279,771,925
Put/Call ratio: 221%
Price per share: $1.53
Number of holders: 103
Value change: -$6,759,847
Number of buys: 52
Number of sells: 53

Quarterly Holders Quick Answers

What is CUSIP 528872302?
CUSIP 528872302 identifies LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 528872302:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Artal Group S.A.	13F	Company	26%	117,553,284	$128,133,000	—	30 Sep 2023	13F
BVF INC/IL	13F	Company	4.5%	19,995,332	$21,794,912	—	30 Sep 2023	13F
FMR LLC	13F	Company	1.7%	7,563,076	$8,243,753	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	1.5%	6,654,966	$7,253,913	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	1.4%	6,400,211	$6,976,230	—	30 Sep 2023	13F
Invus US Partners LLC	3/4/5	Director, 10%+ Owner	— class O/S missing	5,782,749	$6,090,969	—	05 Aug 2022	3/4/5
MILLENNIUM MANAGEMENT LLC	13F	Company	0.87%	3,885,753	$4,235,471	—	30 Sep 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.63%	2,815,034	$3,068,387	—	30 Sep 2023	13F
NEA Management Company, LLC	13F	Company	0.54%	2,382,286	$2,596,692	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.48%	2,126,137	$2,317,837	—	30 Sep 2023	13F
Octagon Capital Advisors LP	13F	Company	0.43%	1,923,076	$2,096,153	—	30 Sep 2023	13F
PINNACLE ASSOCIATES LTD	13F	Company	0.43%	1,912,869	$2,085,027	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	0.42%	1,876,139	$2,044,992	—	30 Sep 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.27%	1,214,678	$1,324,000	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	0.26%	1,150,817	$1,254,389	—	30 Sep 2023	13F
Parkman Healthcare Partners LLC	13F	Company	0.26%	1,136,413	$1,238,690	—	30 Sep 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.19%	851,921	$928,594	—	30 Sep 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.18%	784,122	$854,693	—	30 Sep 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.15%	645,368	$703,451	—	30 Sep 2023	13F
Alyeska Investment Group, L.P.	13F	Company	0.11%	509,484	$555,338	—	30 Sep 2023	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.11%	469,666	$511,935	—	30 Sep 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.09%	409,179	$446,005	—	30 Sep 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.09%	378,701	$412,784	—	30 Sep 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.08%	359,711	$392,085	—	30 Sep 2023	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.08%	337,064	$367,400	—	30 Sep 2023	13F
Bank of New York Mellon Corp	13F	Company	0.07%	331,323	$361,142	—	30 Sep 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	328,506	$358,072	—	30 Sep 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.07%	310,815	$338,845	—	30 Sep 2023	13F
Qube Research & Technologies Ltd	13F	Company	0.06%	277,248	$302,200	—	30 Sep 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.06%	272,255	$297,000	—	30 Sep 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.06%	245,301	$267,378	—	30 Sep 2023	13F
Swiss National Bank	13F	Company	0.05%	242,300	$264,107	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	0.05%	239,620	$261,186	—	30 Sep 2023	13F
ClariVest Asset Management LLC	13F	Company	0.04%	192,398	$210,000	—	30 Sep 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	164,476	$179,279	—	30 Sep 2023	13F
CREDIT SUISSE AG/	13F	Company	0.03%	145,746	$158,863	—	30 Sep 2023	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.03%	137,735	$150,132	—	30 Sep 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	130,291	$142,008	—	30 Sep 2023	13F
UBS Group AG	13F	Company	0.03%	125,362	$136,644	—	30 Sep 2023	13F
VIRTUS ADVISERS, LLC	13F	Company	0.03%	121,711	$132,665	—	30 Sep 2023	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.03%	120,572	$131,423	—	30 Sep 2023	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	117,883	$128,492	—	30 Sep 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.02%	100,691	$110,000	—	30 Sep 2023	13F
Ph.D. Kiernan Seth	3/4/5	VP, Chief Commercial Officer	— mixed-class rows	379,163 mixed-class rows	$104,343	—	28 Feb 2023	3/4/5
Lombard Odier SCmA Compagnie	13F	Individual	0.02%	94,000	$102,460	—	30 Sep 2023	13F
Verition Fund Management LLC	13F	Company	0.02%	91,700	$99,953	—	30 Sep 2023	13F
Legal & General Group Plc	13F	Company	0.02%	83,635	$91,163	—	30 Sep 2023	13F
STIFEL FINANCIAL CORP	13F	Company	0.02%	81,967	$89,344	—	30 Sep 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.02%	81,930	$89,304	—	30 Sep 2023	13F
Squarepoint Ops LLC	13F	Company	0.01%	62,243	$67,845	—	30 Sep 2023	13F

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) as of Q4 2023

As of 31 Dec 2023, LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) was held by 103 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 182,858,180 shares. The largest 10 holders included Artal Group S.A., BVF INC/IL, BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, NEA Management Company, LLC, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, STATE STREET CORP, and AMERIPRISE FINANCIAL INC. This page lists 103 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

109

Q4 2023 holders

103

Holder diff

-6

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.